The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent asthma patients with or without allergic rhinitis.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
198
Change of the asthma control questionnaire scores taken over 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.